Apollon Formularies Plc Result of AGM
January 02 2024 - 3:18AM
UK Regulatory
TIDMAPOL
2 January 2024
Apollon Formularies Plc
Result of AGM
Apollon Formularies plc (AQSE: APOL, "Apollon" or the "Company") is pleased to
announce that following the Company's Annual General Meeting held on 29 December
2023, all resolutions were duly passed.
-ENDS-
For additional information, please visit www.apollon.org.uk or contact:
Apollon Formularies
Tel: +44 771 198 0221
Stene Jacobs stene@apollon.org.uk
Peterhouse Capital Limited (Corporate Adviser)
Tel: +44 207 220 9795
Guy Miller gm@peterhousecapital.com
About Apollon Formularies and Apollon Formularies Jamaica
Apollon Formularies plc is an international medical cannabis and medicinal
mushroom pharmaceutical company headquartered in the United Kingdom. Apollon
Formularies Jamaica Limited is a pharmaceutical company incorporated and
operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed
by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate
(R&D), perform research and development, process, and sell medical cannabis
therapeutic products that include legal medical cannabis to treat various
illnesses under medical supervision.
This information was brought to you by Cision http://news.cision.com
END
(END) Dow Jones Newswires
January 02, 2024 03:18 ET (08:18 GMT)
Apollon Formularies (AQSE:APOL)
Historical Stock Chart
From May 2024 to Jun 2024
Apollon Formularies (AQSE:APOL)
Historical Stock Chart
From Jun 2023 to Jun 2024